Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 May 21;19(5):e0303859. doi: 10.1371/journal.pone.0303859

Association between stringency of lockdown measures and emergency department visits during the COVID-19 pandemic: A Dutch multicentre study

F Marlijn Booij-Tromp 1, Nicole J van Groningen 2, Sebastian Vervuurt 3, Juanita A Haagsma 1,4, Bas de Groot 5, Heleen Lameijer 6, Menno I Gaakeer 7, Jelmer Alsma 8, Pleunie P M Rood 1, Rob J C G Verdonschot 1,*, Marna G Bouwhuis 1
Editor: Vincenzo Alfano9
PMCID: PMC11108187  PMID: 38771835

Abstract

Introduction

The COVID-19 outbreak disrupted regular health care, including the Emergency Department (ED), and resulted in insufficient ICU capacity. Lockdown measures were taken to prevent disease spread and hospital overcrowding. Little is known about the relationship of stringency of lockdown measures on ED utilization.

Objective

This study aimed to compare the frequency and characteristics of ED visits during the COVID-19 outbreak in 2020 to 2019, and their relation to stringency of lockdown measures.

Material and methods

A retrospective multicentre study among five Dutch hospitals was performed. The primary outcome was the absolute number of ED visits (year 2018 and 2019 compared to 2020). Secondary outcomes were age, sex, triage category, way of transportation, referral, disposition, and treating medical specialty. The relation between stringency of lockdown measures, measured with the Oxford Stringency Index (OSI) and number and characteristics of ED visits was analysed.

Results

The total number of ED visits in the five hospitals in 2019 was 165,894, whereas the total number of visits in 2020 was 135,762, which was a decrease of 18.2% (range per hospital: 10.5%-30.7%). The reduction in ED visits was greater during periods of high stringency lockdown measures, as indicated by OSI.

Conclusion

The number of ED visits in the Netherlands has significantly dropped during the first year of the COVID-19 pandemic, with a clear association between decreasing ED visits and increasing lockdown measures. The OSI could be used as an indicator in the management of ED visits during a future pandemic.

Introduction

By the end of December 2019, a novel coronavirus was reported in China, now known as SARS-CoV-2. On February 27th the first COVID-19 patient was reported in the Netherlands [1]. The spread in the Netherlands was partly attributed to so-called super spreader events such as winter vacations and mass gatherings at international sports events and Dutch Carnival [2,3]. Many governments implemented country-wide preventative measures against further spread of the virus, including lockdown measures. Lockdown measures and the stringency of these measures varied across countries and over time [4]. After the introduction of the first measures on March 12th 2020, a partial lockdown was announced in the Netherlands starting on March 23th. The lockdown measures included working at home, closure of schools and childcare, no group meetings (<100 people) and traffic restrictions. The impact of lockdown on daily life was immense and was accompanied by great uncertainty, insecurity and fear in the general population [5,6].

During the pandemic, regular healthcare was downsized in order to increase capacity for the care of COVID-19 patients [7]. The increasing number of COVID-19 patients presenting at the Emergency Department (ED) affected the daily routine and work flow. Therefore, adjustments were made such as redirection of medical personnel and hiring more staff [8]. Meanwhile, there were concerns for drastic decreases in ED visits in other patient categories. Early reports from the first months of lockdown in Italy in 2020 showed a reduction in ED visits as high as 68% [9,10]. Similar reductions were reported in other countries such as Germany, the United Kingdom and the United States [1113]. In these studies, reductions were seen in non-urgent conditions (e.g. mild trauma), but also in life-threatening conditions such as acute coronary syndrome, heart failure and stroke.

Few studies have examined the effect of the pandemic on ED visits in the Netherlands, and focussed mainly on specific patient categories and the first lockdown period [1419]. To our knowledge, the effects of different stringency levels of lockdown measures on ED visits is not studied.

Therefore, the primary aim of this study was to describe the frequency of ED visits during the first year of the COVID-19 pandemic (2020), compared to the prior two years (2018 and 2019) and to the stringency of lockdown measures. The secondary aims were to describe characteristics of ED visits during 2020, compared to 2019 and to the stringency of lockdown measures.

Material and methods

Study design

This retrospective observational multicentre study was conducted in the Netherlands and approved by the Medical Ethics Committee of the Erasmus MC (number 2020–0315). In this study the need for an informed consent was waived due to the retrospective nature of this study and the use of anonymous data. Data were collected from five Dutch hospitals. Two academic hospitals and 3 non-academic hospital located in different regions of the Netherlands. Two of the participating hospitals were part of the Netherlands Emergency Evaluation Database (NEED) [20]. NEED is a Dutch quality registry for EDs containing clinical data from all ED visits from the participating hospitals. A dataset was only available from two participating hospitals for the study period. See supporting information S1 Table for hospital characteristics.

Study population and data collection

The frequency and characteristics of ED visits from February 1st, 2019 to January 31st 2020 (year 2019), and February 1st 2020 until January 31st 2021 (COVID-year 2020) were collected. The total number of ED visits of 2019 and 2020 were compared to the reference year 2018. Characteristics of ED visits were; date of the ED visit, age, sex, triage category according to Manchester Triage System (MTS), means of transportation to the ED, referral (e.g. general practitioner, self-referral), destination after ED discharge, and medical specialty (as described below). The Manchester Triage System was used for triage upon arrival at the ED in all five hospitals. Data were extracted from the electronic patient files and the NEED. Data were accessed for research purposes between June 3rd, 2021 until December 30th 2021. Authors had access to pseudonymized data only.

The following main categories for medical specialties were used; surgery (including orthopaedics and plastic surgery), internal medicine (including pulmonology, geriatric medicine, rheumatology, gastroenterology), cardiology (including thoracic surgery), neurology (including neurosurgery), other surgical (including urology, ophthalmology, otorhinolaryngology), paediatrics and others (including gynaecology, intensive care, anaesthesiology, dermatology, psychiatry).

The stringency level of lockdown measures can be defined with the Oxford Stringency Index (OSI). The OSI is an index measuring international government responsiveness during the COVID-19 pandemic and ranges from 1 to 100, with a higher index indicating more and stricter lockdown measures [4].

Statistical analysis

Descriptive statistics were used to assess the total number of ED visits in 2018, 2019 and 2020. Chi-square tests (categorical variables) and the Mann-Whitney U test and the independent sample T-test (continuous variables) were used to test for differences in characteristics of ED visits between 2019 and 2020. In addition, the number of ED visits (2020) was plotted against the OSI to determine if there was an association between the level of lockdown measures and the number of ED visits.

In order to determine if characteristics of the ED visits (2020) differed across periods with varying OSI, the OSI was divided into five categories: category 1; 0.00–0.99, category 2; 1.00–25.99, category 3; 26.00–50.99, category 4; 51.00–75.99, category 5; 76.00–100 and Chi-square and one-way ANOVA were used to test for differences. Analyses were done per month or per week. Statistical analyses were performed with IBM Statistics 27. A p-value of <0.05 was considered statistically significant.

Results

Number of ED visits

The total number of ED visits in 2018 and 2019 were 164,290 and 165,894 respectively. For 2020 the total number of visits was 135,762. The decrease in ED visits averaged 18.2%, and ranged by hospital from a low of 10.5% to a high of 30.7% (Table 1).

Table 1. Annual number of ED visits, total and by hospital.

Hospitals Total
H1 H2 H3 H4 H5
2018 32,553 44,397 34,491 27,141 25,708 164,290
2019 33,101 45,328 35,576 26,154 25,735 165,894
Growth PY
(2019 vs 2018)
1.7% 2.1% 3.1% -3.6% 0.1% 1.0%
2020 25,389 38,901 30,303 18,126* 23,043 135,762
Growth PY
(2020 vs 2019)
-23.3% -14.2% -14.8% -30.7% -10.5% -18.2%

Growth PY = growth relative to prior year (%).H = Hospital.

*Missing data of the last three weeks for H4 (2020).

Fig 1 shows the number of ED visits per week in the study period. The difference in number of ED visits per week between 2019 and 2020 was higher during the first, second and third peak wave of COVID-19 in the Netherlands. The greatest reduction in ED visits was 34%, seen in the first month after the introduction of the first lockdown measures in the Netherlands (week 11–15). The trends in the reduction in ED visits were similar across all hospitals, with slight variations in the magnitude of reductions (Fig 2).

Fig 1. Total weekly ED visits per year.

Fig 1

P1 = First Covid Peak, P2 = Second Covid Peak, P3 = Third Covid Peak. *Missing data of the last three weeks for H4 (2020).

Fig 2. Difference in ED visits in all participating hospitals in 2020 compared to 2019 in percent per hospital per month.

Fig 2

H = hospital *Missing data of the last three weeks for H4 (2020).

In 2020, the OSI in the Netherlands ranged from 0 (no lock down measures) to 82. Fig 3 shows the number of ED visits compared to the OSI; when OSI increased, the number of ED visits decreased, and vice versa.

Fig 3. Weekly total ED visits and Oxford Stringency Index (OSI) in 2020.

Fig 3

OSI = Oxford Stringency Index. Index for the measurements taken by the government, ranging from 1 (no measurements) to 100 (very strict measurements with a high impact).

Characteristics of ED visits

The characteristics of the ED visits are shown in Table 2. No relevant differences in age and sex were found between 2019 and 2020. The mean age was 48.1 and 50.8 years, for 2019 and 2020 respectively. In 2019, 52.2% of the patients were male versus 52.8% in 2020. In 2020, a decrease was observed for all age categories with the largest decrease in the category ≤ 17 years (relative difference of -28.4%). In addition, relatively more patients in age category ≥ 70 years were seen in 2020 compared to 2019 (28.6% versus 26.0%; p<0.001).

Table 2. Characteristics of the ED visits.


2019 2020 Abs. difference (N) Rel. difference (%) Missings p-value
Abs. Rel. (%) Abs. Rel. (%)      N  %  
Sex Male 85,636 52.2 69,526 52.7 -16,110 -18.8 101 0.0% <0.001
  Female 78,396 47.8 62,139 47.3 -16,257 -20.7      
Age Mean (years) 48.1   50.8    - none <0.001
Age category ≤ 17 years 25,636 15.6 18,353 13.9 -7,283 -28.4 none <0.001
  18–69 years 95,792 58.4 75,693 57.5 -20,099 -21.0    
  ≥ 70 years 42,658 26.0 37,666 28.6 -4,992 -11.7      
MTS category Blue 2,609 1.7 2,568 2.0 -41 -1.6 17,073 5.8% <0.001
  Green 52,174 34.1 40,476 32.2 -11,698 -22.4      
  Yellow 68,774 44.9 57,285 45.6 -11,489 -16.7      
  Orange 27,610 18.0 23,321 18.6 -4,289 -15.5      
  Red 2,000 1.3 1,908 1.5 -92 -4.6      
Transportation Own 115,905 72.3 85,674 67.2 -30,231 -26.1 8,068 2.7% <0.001
  Ambulance 44,305 27.7 41,846 32.8 -2,459 -5.6      
Referral Self 70,224 43.0 54,409 41.6 -15,815 -22.5 1,785 0.6% <0.001
  GP 82,906 50.7 67,157 51.4 -15,749 -19.0      
  Specialist 10,233 6.3 9,084 7.0 -1,149 -11.2      
Disposition Left on own accord 151 0.1 104 0.1 -47 -31.1 1,077 0.4% <0.001
  Home 71,077 43.4 54,292 41.4 -16,785 -23.6      
  Admissions 59,562 35.5 54,700 41.0 -4,862 -8.2      
   • CU/MCU 166 0.1 141 0.1 -25 -15.1      
   • ICU 1,378 0.8 855 0.7 -523 -38.0      
  Deceased* 2,462 1.5 447 0.3 -2,015 -81.8      
  Transfer 3,019 1.8 1,817 1.4 -1,202 -39.8      
  Outpatient Clinic 22,692 13.9 18,205 13.9 -4,487 -19.8      
  GP 4,695 2.9 1,498 1.1 -3,197 -68.1      
Medical specialty Surgery 41,560 39.6 33,157 38.5 -8,403 -20.2 104,803 35.4% <0.001
  Internal Medicine 32,826 31.3 28,881 33.5 -3,945 -12.0      
  Cardiology 4,628 4.4 3,670 4.3 -958 -20.7      
  Neurology 11,595 11.1 9,856 11.4 -1,739 -15.0      
  Other surgical 5,322 5.1 4,368 5.1 -954 -17.9      
  Paediatrics 7,684 7.3 5,057 5.9 -2,627 -34.2      
  Others^ 1,260 1.2 1,131 1.3 -129 -10.2      

GP = general practitioner/family doctor, MTS = Manchester Triage System, CCU = Cardiac Care Unit, MCU = Medium Care Unit, ICU = Intensive Care Unit.

* Deceased during ED visit.

^ Gynaecology, Intensive Care, Anesthesiology, Dermatology, Psychiatry.

In 2020, relatively more yellow, orange and red triaged patients, and relatively less green triaged patients by MTS were seen. Also, a greater percentage of patients arrived by ambulance (27.7% in 2019 versus 32.8% in 2020; p<0.001). Furthermore, self-referrals were relatively lower (43.0% in 2019 versus 41.6% in 2020; p<0.001), and referrals by the general physician were higher (50.7% in 2019 versus 51.4% in 2020, p<0.001). The admission rate was higher (35.5% in 2019 versus 41.0% in 2020, p<0.001), but the ICU admission rate was slightly lower (0.8% in 2019 versus 0.7% in 2020, p<0.001). Relatively less surgery and paediatric patients were seen, but relatively more patients for internal medicine, including pulmonology.

Table 3 shows the characteristics of the ED visits by OSI category. As the OSI increased, the mean age increased accordingly. More specifically, the percentage of patients in the age category ≤ 17 years decreased, whereas the patients in the age category ≥ 70 years increased (p<0.001). With an OSI >25, a decrease in the percentage of green triage category and an increase in the percentage of yellow, orange and red triage categories was observed (p<0.001).

Table 3. ED visits characteristics by Oxford Stringency Index category.

Oxford Stringency Index category p-value
0.00–0.99 1.00–24.99 25.00–50.99 51.00–74.99 75.00–100
Sex Male 52.2% 53.5% 52.8% 52.9% 52.7% 0.019
Age Mean (years) 48.2 48.9 49.3 50.5 52.5 <0.001
Age category ≤ 17 years
18–69 years
≥ 70 years
15.6%
58.3%
26.1%
15.7%
56.2%
28.1%
15.0%
57.7%
27.3%
14.1%
57.3%
28.6%
11.4%
57.8%
30.7%
<0.001
MTS category Blue
Green
Yellow
Orange
Red
1.7%
34.0%
44.9%
18.1%
1.3%
2.0%
33.0%
45.0%
18.9%
1.0%
2.1%
34.4%
44.3%
17.8%
1.4%
2.0%
31.8%
45.9%
18.7%
1.6%
2.0%
29.7%
47.4%
19.2%
1.7%
<0.001
Transportation Own
Ambulance
72.3%
27.7%
72.0%
28.0%
68.1%
31.9%
66.8%
33.2%
64.1%
35.9%
<0.001
Referral Self
GP
Specialist
42.9%
50.8%
6.3%
41.7%
50.6%
7.7%
40.8%
52.6%
6.7%
40.7%
52.2%
7.1%
44.8%
48.4%
6.9%
<0.001
Disposition Left on own accord
Home
Admission
 • CCU/MCU
 • ICU
Deceased*
Transfer
Outpatient clinic
GP
0.1%
43.4%
35.5%
0.1%
0.9%
1.5%
1.8%
13.8%
2.9%
0.1%
43.1%
36.6%
0.1%
0.8%
1.2%
1.8%
13.9%
2.5%
0.1%
43.4%
39.2%
0.1%
0.6%
0.2%
1.5%
14.1%
0.7%
0.1%
41.8%
41.5%
0.1%
0.6%
0.2%
1.2%
13.5%
1.1%
0.1%
37.1%
45.1%
0.1%
0.5%
0.2%
1.2%
14.6%
0.9%
<0.001
Medical specialty Surgery
Internal medicine
Cardiology
Neurology
Other surgical
Paediatrics
Others^
39.5%
31.3%
4.4%
11.1%
5.1%
7.3%
1.2%
36.2%
34.1%
3.8%
12.2%
5.4%
7.3%
1.1%
41.7%
30.5%
4.2%
11.3%
5.0%
6.0%
1.3%
38.7%
33.4%
4.3%
11.5%
4.9%
5.8%
1.3%
35.0%
38.5%
4.1%
11.2%
5.1%
4.8%
1.4%
<0.001

GP = general practitioner/family doctor, MTS = Manchester Triage System, CCU = Cardiac Care Unit, MCU = Medium Care Unit, ICU = Intensive Care Unit.

* Deceased during ED visit.

^ Gynaecology, Intensive Care, Anesthesiology, Dermatology, Psychiatry.

Furthermore, as the OSI increased a higher percentage of patients arrived by ambulance and the admission rate increased (both p<0.001). Also a higher OSI was associated with a lower percentage of ED visits for paediatrics. In the highest OSI category (75.00–100.00), most ED visits were patients for internal medicine.

Discussion

This study compared frequency and characteristics of ED visits in five Dutch hospitals during the first year of COVID-19 with the pre-pandemic year. To our knowledge, this study it is the first to investigate the association of stringency of lockdown measures on the frequency and characteristics of ED visits as well. The results show a considerable reduction of ED visits in all participating hospitals, although the magnitude of the reduction differed across hospitals and subgroups of patients. Moreover, the number of ED visits appeared to be inversely related to the stringency of lockdown measures. Reductions were mainly seen in patients ≤ 17 years. In addition, it appeared that patients were more severely ill compared to 2019, since triage categories were higher, patients presented by ambulance more often, and admission rates were higher.

The current study shows a significant reduction in ED visits of 18.2% in 2020 compared to 2019. Reductions were most pronounced during the first peak wave with a reduction of 34% in the first weeks of lockdown. Other studies from the Netherlands and other countries worldwide showed similar trends [16,19,2125]. This decline in patient numbers is most likely multifactorial. First, a major reduction in injuries was reported during the pandemic which can be expected as workplace activities, outdoor activities, traffic and nightlife were increasingly restricted [14,15,18]. Second, elective surgeries were postponed which led to fewer patients presenting with postoperative complications [26]. Third, psychological effects played a role as well. One study in the Netherlands reported that patients delayed their visit to the ED in great part due to fear of COVID-19 infection, the wish to not further burden medical professionals, stay at home instructions issued by referring professionals, and the perception of non-urgency of their own complaints compared to COVID-19 patients [27]. The second and third peak wave showed repeated reductions in ED visits, although these were less pronounced than in the first wave. Psychological effects could have worn off as COVID-19 became a part of everyday life and vaccinations were developed, which may have caused decreased adherence to lockdown measures and more ED visits as everyday activities were partly resumed. One study reported that low patient numbers persisted beyond the first and second year of the pandemic, and the authors theorised that this could be permanent as some patients have resorted to other means of healthcare such as telemedicine [24].

The current study shows a relatively higher mean age during the pandemic, with greater absolute and relative reductions in children compared to elderly. Other studies showed similar results [19,2123,25]. Kruizinga et al. showed that paediatric ED visits in the Netherlands were reduced by 59% in the first half of 2020 with the greatest reductions in infectious diseases [17]. This could be explained by fewer child-to-child interactions and outside activities, decreasing the chances for infection and trauma.

In 2020, the absolute number of elderly patients visiting the ED was lower. This is in line with the study of Dijk et al. [19] In addition to the aforementioned possible reasons, this could be explained to the fact that many elderly died at home or in nursing homes, since COVID-19 infection rates and thereby death rates in nursing homes were high [28,29]. However, relatively more elderly visited the ED, as they were more prone to infection due to higher frailty.

Our study showed a remarkable decrease in ICU admissions and ED mortality in 2020, both in absolute and relative numbers. This is possibly due to the fact that severely ill elderly patients were not admitted to the hospitals during the Covid-19 outbreak anymore and died at home or in nursing homes. And in general, severely ill patients were sent to the ICU expeditiously in order to facilitate the ED.

Patient numbers for all specialties decreased, mostly for surgery and paediatrics and least for internal medicine. Other studies showed an initial sharp decline in severe conditions (acute myocardial infarction, stroke, and sepsis) followed by a recovery phase, with overall numbers remaining low during the first wave [2123,30]. In other studies, ED visits for trauma followed the same trend [19,21,22,25]. A reduction of trauma in Dutch studies was up to 37% in the first months of the pandemic [14,15,18,19].

As the OSI increased, the mean age increased, triage categories increased (yellow, orange and red), more patients arrived by ambulance, and admission rates were higher. Significantly less paediatric patients and more internal medicine patients visited the ED with increased OSI. Given these association between OSI and ED visits, the stringency of lockdown measures might be helpful to predict ED visits and adapt ED policy during a pandemic (e.g. shifting from conventional healthcare to contingency of crisis level of healthcare) [31].

EDs need to be prepared to manage disasters and crises, such as the COVID-19 pandemic, in the short and long term. Sharing the lessons learned during the pandemic is essential [32]. Importantly, an increasing trend in incidence of internal hospital crises and disasters is observed in the Netherlands, requiring emergency managers to adapt their hospital disaster plans and hospital staff to receive regular training with crisis response templates [33,34].

Strengths and limitations

This is the largest multicentre study describing the impact of the COVID-19 pandemic on all ED visits in Europe. The participating hospitals are representative for the situation in the Netherlands based on geographical location and included both academic and non-academic hospitals. In contrast to other studies it describes ED visits over a full-year period covering multiple peak waves. Furthermore, it is the first study to investigate the association between ED patient and visit characteristics with the OSI.

Unfortunately, one of the participating hospitals could not provide data from the last three weeks of the COVID year. This probably led to some overestimation of the reduction in ED visits, however it only effected the last month. Further, there was a high heterogeneity in documentation of secondary outcomes between different hospital databases, making detailed analysis challenging. Data on mortality in the ED was often incomplete, which made it difficult to interpret. Medical specialties needed to be pooled for reliable analysis, meaning no statistics on specific diseases could be collected. The increased percentage of internal medicine patients was probably caused by COVID-19 patients that were mainly seen by this specialty. During the start of the pandemic no specific diagnosis registration code existed for COVID-19 infections, which made it not possible to assess the number of COVID-19 patients during the study period.

Recommendations

Lockdown measures have effects on ED visits during a pandemic. Greater uniformity in the registration of patient characteristics enables a more detailed analysis of these effects. Availability of real-time data on ED visits during a pandemic enables policy makers and healthcare managers to assess the impact of measures directly, and to adjust accordingly. An indicator like OSI with a clear association with ED visits and patient characteristics might be beneficial, although further validation is needed.

Conclusion

The number of ED visits in the Netherlands have significantly dropped during the first year of the COVID-19 pandemic, with a clear association between decreasing ED visits and increasing lockdown measures. Overall, patients seemed more severely ill as triage categories and admission rates were higher, especially with higher OSI. The OSI could be a useful indicator in the management of ED visits and for patient characteristics during a future pandemic.

Supporting information

S1 Table. Hospital characteristics.

H = Hospital, ICU = Intensive Care Unit, MCU = Medium Care Unit, CCU = Cardiac Care Unit, GP = general practitioner/family doctor, PCI = Percutaneous Coronary Intervention.

(DOCX)

pone.0303859.s001.docx (19.9KB, docx)

Data Availability

There are legal restrictions concerning data sharing. In the data sharing agreement with the Netherlands Emergency Evaluation Database (NEED) it was stated (and signed for) that the data would not be provided to a third party, in line with the General Data Protection Regulation (GDPR). Also in the data sharing agreements with the other two hospitals it was stated (and signed for) that the data would not be shared to a third party. This is in line with Erasmus Medical Center policy. The ethical body mandating the restriction of this data is our legal department. Mr. L. Stoffel LLM. – advisor data protection and privacy, and coordinator information safety – can be contacted for this via email address: l.stoffel@erasmusmc.nl.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious diseases. 2020;20(5):533–4. doi: 10.1016/S1473-3099(20)30120-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chen Q, Toorop MMA, De Boer MGJ, Rosendaal FR, Lijfering WM. Why crowding matters in the time of COVID-19 pandemic- A lesson from the carnival effect on the 2017/2018 influenza epidemic in the Netherlands. BMC Public Health. 2020;20(1). doi: 10.1186/s12889-020-09612-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gabutti G D ’anchera E, De Motoli F, Savio M, Stefanati A. The epidemiological characteristics of the covid-19 pandemic in europe: Focus on Italy. International Journal of Environmental Research and Public Health: MDPI AG; 2021. p. 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hale T, Petherick A, Phillips T, Boby T, Andretti de Mello B. COVID-19 Government Response Tracker. [Google Scholar]
  • 5.Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. Journal of anxiety disorders. 2020;74:102258–. doi: 10.1016/j.janxdis.2020.102258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Necho M, Tsehay M, Birkie M, Biset G, Tadesse E. Prevalence of anxiety, depression, and psychological distress among the general population during the COVID-19 pandemic: A systematic review and meta-analysis. The International journal of social psychiatry. 2021;67(7):892–906. doi: 10.1177/00207640211003121 [DOI] [PubMed] [Google Scholar]
  • 7.De spoedeisende hulp in de coronacrisis opeens is alles een leermoment. Het Parool2020.
  • 8.O’Connor RD, Barten DG, Latten GHP. Preparations of Dutch emergency departments for the COVID-19 pandemic: A questionnaire-based study. PloS one. 2021;16(9):e0256982–e. doi: 10.1371/journal.pone.0256982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Giamello JD, Abram S, Bernardi S, Lauria G. The emergency department in the COVID-19 era. Who are we missing? European Journal of Emergency Medicine: Lippincott Williams and Wilkins; 2020. p. 305–6. doi: 10.1097/MEJ.0000000000000718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Solbiati M, Russo L, Beverina A, Groff P, Strada A, Furlan L, et al. Examination of the relationship between emergency department presentations and population mortality: a multicenter analysis of emergency department presentations during the COVID-19 pandemic. European Journal of Internal Medicine. 2021;94:34–8. doi: 10.1016/j.ejim.2021.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bergrath S, Strapatsas T, Tuemen M, Reith T, Deussen M, Aretz O, et al. Impact of the COVID-19 pandemic on emergency medical resources: An observational multicenter study including all hospitals in a major urban center of the Rhein-Ruhr metropolitan region. Anaesthesist. 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Flynn D, Moloney E, Bhattarai N, Scott J, Breckons M, Avery L, et al. COVID-19 pandemic in the United Kingdom. Health policy and technology. 2020;9(4):673–91. doi: 10.1016/j.hlpt.2020.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jeffery MM, D’Onofrio G, Paek H, Platts-Mills TF, Soares WE, Hoppe JA, et al. Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US. JAMA internal medicine. 2020;180(10):1328–33. doi: 10.1001/jamainternmed.2020.3288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Van Aert GJJ, Van Der Laan L, Boonman-De Winter LJM, Berende CAS, De Groot HGW, Boele Van Hensbroek P, et al. Effect of the COVID-19 pandemic during the first lockdown in the Netherlands on the number of trauma-related admissions, trauma severity and treatment: The results of a retrospective cohort study in a level 2 trauma centre. BMJ Open. 2021;11(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Krul IM, Panneman MJM, Toet H, Stam C, Blatter BM. The effect of the corona measures on the number of injuries treated at Emergency Departments. Nederlands tijdschrift voor geneeskunde. 2021;165(D5760). [PubMed] [Google Scholar]
  • 16.Barten DG, Latten GHP, Van Osch FHM. Reduced emergency department utilization during the early phase of the COVID-19 pandemic: Viral fear or lockdown effect. Disaster Medicine and Public Health Preparedness. 2020. doi: 10.1017/dmp.2020.303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kruizinga MD, Peeters D, van Veen M, van Houten M, Wieringa J, Noordzij JG, et al. The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature. European journal of pediatrics. 2021;180(7):2271–9. doi: 10.1007/s00431-021-04015-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hakkenbrak NAG, Loggers SAI, Lubbers E, de Geus J, van Wonderen SF, Berkeveld E, et al. Trauma care during the COVID-19 pandemic in the Netherlands: a level 1 trauma multicenter cohort study. Scandinavian journal of trauma, resuscitation and emergency medicine. 2021;29(1):130–. doi: 10.1186/s13049-021-00942-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dijk R, Plaum P, Tummers S, van Osch FHM, Barten DG, Latten GHP. First and second wave dynamics of emergency department utilization during the COVID-19 pandemic: A retrospective study in 3 hospitals in The Netherlands. PloS one. 2023;18(2):e0279105–e. doi: 10.1371/journal.pone.0279105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Netherlands Emergency department Evaluation Database (NEED).
  • 21.Morello F, Bima P, Ferreri E, Chiarlo M, Balzaretti P, Tirabassi G, et al. After the first wave and beyond lockdown: long-lasting changes in emergency department visit number, characteristics, diagnoses, and hospital admissions. Internal and Emergency Medicine. 2021;16(6):1683–90. doi: 10.1007/s11739-021-02667-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wyatt S, Mohammed MA, Fisher E, McConkey R, Spilsbury P. Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study. Lancet Reg Health Eur. 2021;2:100034. doi: 10.1016/j.lanepe.2021.100034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Venkatesh AK, Janke AT, Shu-Xia L, Rothenberg C, Goyal P, Terry A, et al. Emergency Department Utilization for Emergency Conditions During COVID-19. Annals of emergency medicine. 2021;78(1):84–91. doi: 10.1016/j.annemergmed.2021.01.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Melnick G O ’Leary JF, Zaniello BA, Abrishamian L. COVID-19 driven decline in emergency visits: Has it continued, is it permanent, and what does it mean for emergency physicians? The American journal of emergency medicine. 2022;61:64–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wai AKC, Wong CKH, Wong JYH, Xiong X, Chu OCK, Wong MS, et al. Changes in Emergency Department Visits, Diagnostic Groups, and 28-Day Mortality Associated With the COVID-19 Pandemic: A Territory-Wide, Retrospective, Cohort Study. Annals of Emergency Medicine. 2022;79(2):148–57. doi: 10.1016/j.annemergmed.2021.09.424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chesser TJS, Handley R, Kloos J, De Wachter G, Putzeys G, Gómez-Vallejo J, et al. International trauma care: initial European approaches during the COVID 19 pandemic. OTA International: The Open Access Journal of Orthopaedic Trauma. 2021;4(1S):e112–e. doi: 10.1097/OI9.0000000000000112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nab M, van Vehmendahl R, Somers I, Schoon Y, Hesselink G. Delayed emergency healthcare seeking behaviour by Dutch emergency department visitors during the first COVID-19 wave: a mixed methods retrospective observational study. BMC Emergency Medicine. 2021;21(1):56–. doi: 10.1186/s12873-021-00449-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Backhaus R, Verbeek H, de Boer B, Urlings JHJ, Gerritsen DL, Koopmans RTCM, et al. From wave to wave: a Dutch national study on the long-term impact of COVID-19 on well-being and family visitation in nursing homes. BMC geriatrics. 2021;21(1):588–. doi: 10.1186/s12877-021-02530-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rutten JJS, van Loon AM, van Kooten J, van Buul LW, Joling KJ, Smalbrugge M, et al. Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors. Journal of the American Medical Directors Association. 2020;21(12):1791–7.e1. doi: 10.1016/j.jamda.2020.10.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Janke AT, Jain S, Hwang U, Rosenberg M, Biese K, Schneider S, et al. Emergency department visits for emergent conditions among older adults during the COVID-19 pandemic. Journal of the American Geriatrics Society. 2021;69(7):1713–21. doi: 10.1111/jgs.17227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hick JL, Barbera JA, Kelen GD. Refining surge capacity: conventional, contingency, and crisis capacity. Disaster Med Public Health Prep. 2009;3(2 Suppl):S59–67. doi: 10.1097/DMP.0b013e31819f1ae2 [DOI] [PubMed] [Google Scholar]
  • 32.Schreyer KE, Del Portal DA, King LJL, Blome A, DeAngelis M, Stauffer K, et al. Emergency Department Management of the Covid-19 Pandemic. J Emerg Med. 2020;59(6):946–51. doi: 10.1016/j.jemermed.2020.07.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Klokman VW, Barten DG, Peters N, Versteegen MGJ, Wijnands JJJ, van Osch FHM, et al. A scoping review of internal hospital crises and disasters in the Netherlands, 2000–2020. PLoS One. 2021;16(4):e0250551. doi: 10.1371/journal.pone.0250551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Milliken A JM, Sadovnikoff N, Feldman WB, Shah SB, Galluzzo M et al. Addressing Challenges Associated with Operationalizing a Crisis Standards of Care Protocol for the Covid-19 Pandemic. NEJM Catalyst. 2020. [Google Scholar]

Decision Letter 0

Vincenzo Alfano

12 Feb 2024

PONE-D-23-40778Association between stringency of lockdown measures and Emergency Department visits during the COVID-19 pandemic: a Dutch multicentre studyPLOS ONE

Dear Dr. VERDONSCHOT,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please carefully address all the issues highlighted by the referees. In particular, I believe that the public health/disaster medicine side of discussion has much room to be improved. 

Please submit your revised manuscript by Mar 28 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Vincenzo Alfano

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

3. Please include a separate caption for each figure in your manuscript.

4. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"" files

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a retrospective, multicenter study in 5 Dutch hospitals on the association between ED utilization and the stringency of lockdown measures. Although numerous publications have emerged on ED utilization patterns during the pandemic, this manuscript is interesting because it assesses the association with the OSI index. However, there are some minor concerns and the English language could be improved throughout the manuscript.

GENERAL

The English language could be improved throughout the manuscript, particularly with regards to grammar and style. Some sentences are a little bit odd.

ABSTRACT

- I would refrain from u- sing "usual" healthcare; consider "regular" instead

- You state that little is known about the influence of lockdown on ED visits. This is not true and has been extensively studied. You are right about that little is known about the association of ED utilization and OSI.

- The number of ED visits "have": should be "has"

- I think there is a better wording than "tool" for OSI; maybe indicator is better (also in main article discussion and conclusion)

INTRODUCTION

- COVID-19 is the diseaese that is caused by SARS-CoV-2, so this is not exactly the same.

- Preventative measures do not only represent lockdown measures (such as social distancing, increased hygiene measures, etc), so this part should be rephrased. It would also be good to underline that there is a great variety in lockdown; in the netherlands there never was a lockdown as stringent as in China. So consider to explain a bit more what the (first) lockdown looked like.

- Line 81-82: consider to use the word reference years instead of the two prior years.

METHODS

no specific comments

RESULTS

no specific comments

DISCUSSION

- Good discussion of the present literature

- Line 224: I doubt if vaccination development played a role at that time, because they were not available yet.

- Line 246: consider using ED mortality instead of deceases

Reviewer #2: This study depicts the ED fluxes of patients during the first part of the COVID-19 pandemics, discussing some useful insights for future public health measures.

I think the paper is balanced in its sections; some minor suggestions here:

- comparison 2018+2019 vs 2020 as primary aim but not present in the abstract; maybe just worth mentioning it.

- maybe internal medicine visits preserved an increased trend because only complex cases (usually managed by IM, especially if elderly and if geriatrics not present) bypassed the patients' fear to access EDs.

- relationships between higher ORI and negative consequences can be speculated; e.g. higher ORI could mean higher mortality or excess mortality; similar to the choice of shifting from conventional to contingency to crisis level of healthcare [ DOI: 10.1097/DMP.0b013e31819f1ae2 ; 10.1056/CAT.20.0384 ] so a message for stakeholders: you can choose to apply stricter measures, but expect consequences on population health.

Thank you for letting me review this paper.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 May 21;19(5):e0303859. doi: 10.1371/journal.pone.0303859.r002

Author response to Decision Letter 0


18 Apr 2024

Responses to all the questions and comments of the editor and reviewers can be found in the Response to the Reviewers document as attached. Also find our Statement on Data Sharing attached separately.

Attachment

Submitted filename: Response_to_the_reviewers_25032024.docx

pone.0303859.s002.docx (20.4KB, docx)

Decision Letter 1

Vincenzo Alfano

2 May 2024

Association between stringency of lockdown measures and Emergency Department visits during the COVID-19 pandemic: a Dutch multicentre study

PONE-D-23-40778R1

Dear Dr. VERDONSCHOT,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vincenzo Alfano

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

All concerns are now sufficiently addressed.

Great paper. Thank you for letting me review it.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Vincenzo Alfano

10 May 2024

PONE-D-23-40778R1

PLOS ONE

Dear Dr. VERDONSCHOT,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vincenzo Alfano

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Hospital characteristics.

    H = Hospital, ICU = Intensive Care Unit, MCU = Medium Care Unit, CCU = Cardiac Care Unit, GP = general practitioner/family doctor, PCI = Percutaneous Coronary Intervention.

    (DOCX)

    pone.0303859.s001.docx (19.9KB, docx)
    Attachment

    Submitted filename: Response_to_the_reviewers_25032024.docx

    pone.0303859.s002.docx (20.4KB, docx)

    Data Availability Statement

    There are legal restrictions concerning data sharing. In the data sharing agreement with the Netherlands Emergency Evaluation Database (NEED) it was stated (and signed for) that the data would not be provided to a third party, in line with the General Data Protection Regulation (GDPR). Also in the data sharing agreements with the other two hospitals it was stated (and signed for) that the data would not be shared to a third party. This is in line with Erasmus Medical Center policy. The ethical body mandating the restriction of this data is our legal department. Mr. L. Stoffel LLM. – advisor data protection and privacy, and coordinator information safety – can be contacted for this via email address: l.stoffel@erasmusmc.nl.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES